- Home
- CJET vs SNTI Comparison
CJET vs SNTI Comparison
Compare CJET & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJET
- SNTI
- Stock Information
- Founded
- CJET 2009
- SNTI 2016
- Country
- CJET China
- SNTI United States
- Employees
- CJET N/A
- SNTI N/A
- Industry
- CJET Auto Manufacturing
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- CJET Consumer Discretionary
- SNTI Health Care
- Exchange
- CJET Nasdaq
- SNTI Nasdaq
- Market Cap
- CJET 11.0M
- SNTI 10.4M
- IPO Year
- CJET N/A
- SNTI N/A
- Fundamental
- Price
- CJET $2.01
- SNTI $4.41
- Analyst Decision
- CJET
- SNTI Strong Buy
- Analyst Count
- CJET 0
- SNTI 1
- Target Price
- CJET N/A
- SNTI $12.00
- AVG Volume (30 Days)
- CJET 9.5K
- SNTI 7.0M
- Earning Date
- CJET 12-31-2024
- SNTI 11-14-2024
- Dividend Yield
- CJET N/A
- SNTI N/A
- EPS Growth
- CJET N/A
- SNTI N/A
- EPS
- CJET N/A
- SNTI N/A
- Revenue
- CJET $10,275,000.00
- SNTI N/A
- Revenue This Year
- CJET N/A
- SNTI $254.47
- Revenue Next Year
- CJET N/A
- SNTI $169.66
- P/E Ratio
- CJET N/A
- SNTI N/A
- Revenue Growth
- CJET 31.31
- SNTI N/A
- 52 Week Low
- CJET $1.77
- SNTI $1.52
- 52 Week High
- CJET $30.00
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- CJET 47.19
- SNTI 52.77
- Support Level
- CJET $2.02
- SNTI $4.62
- Resistance Level
- CJET $2.07
- SNTI $5.96
- Average True Range (ATR)
- CJET 0.13
- SNTI 1.63
- MACD
- CJET -0.01
- SNTI -0.14
- Stochastic Oscillator
- CJET 25.88
- SNTI 18.48
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the research and development, production and sales of new energy vehicles. New energy vehicles refer to plug-in electric vehicles including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.